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Sunlmary 
To investigate the role of CD8 + T lymphocytes in recovery from influenza pneumonia, we used 
transgenic mice either homozygous (-/-)  or heterozygous (+/-)  for fl2-microglobulin (fl2-M) 
gene disruption.  These mice lack major histocompatibility complex-restricted class I (CD8 +) 
T  cells.  We found that  after challenge with a nonlethal influenza virus, the fl2-M (-/-)  mice 
had significantly delayed pulmonary viral clearance.  Furthermore,  after challenge with a more 
virulent  influenza virus,  the fl2-M (-/-)  mice had a significantly higher  mortality rate than 
did  control  mice.  Thus,  CD8 +  T  cells  are  important  in  recovery from  virulent  influenza 
infections, but other host defense mechanisms  can clear the respiratory tract of more benign 
infections. 
M 
ice infected with influenza virus generate class I MHC- 
restricted  CD8 +  cytotoxic  T  lymphocytes  that  in 
vitro lyse influenza-sensitized  targets and that in vivo func- 
tion to clear the respiratory tract infection and promote clin- 
ical recovery (1). Experimental data supporting this paradigm 
come from studies  in mice that  have been adoptively im- 
munized by antiinfluenza CD8 + splenocytes or clones (2-5). 
These studies showed that mice receiving such cells had re- 
duced mortality and more efficient viral clearance after infec- 
tion with  influenza  virus  (2-5). 
Whether class II MHC-restricted T cells can also function 
to clear virus is currently under investigation. After adoptive 
transfer of class  II cytolytic clones, mice have been shown 
to clear virus (6). Eichelberger et al.  (7)  addressed the role 
of CD4 + T cells by using mice that either had been depleted 
of CD8 § T  cells by in vivo treatment with anti-CD8 mAb, 
or had disrupted flE-microglobulin (fl2-M) genes. Their data 
suggested that these mice cleared virus similarly to normal 
mice (7),  and cast some doubt on the relative importance 
of CD8 + T  cells  in host defense against  viral infections. 
In this report,  we also used transgenic  homozygous for 
the fl2-M defect and found that although these animals can 
eventually eliminate influenza virus from their lungs, clear- 
ance is significantly delayed. Further, these animals are more 
susceptible to death from a more virulent strain of influenza 
virus. 
Materials and Methods 
Mice.  Mice were housed under barrier conditions at the trans- 
genie animal facility of the University of Florida, Gainesville. Mice 
transgenic for a homozygous (-/-) or heterozygous (+/-) gene 
disruption  for firM were derived from a breeding pair obtained 
from Dr. O. Smithies, University of North Carolina, Chapel Hill, 
NC (8). PCR was Used to screen for the mutation and confirmed 
by Southern blot hybridization (8). Control mice were C57BL/6. 
All mice were females and 4-16 wk old when used. 
Viruses.  Two viruses were used: influenza A/Port Chalmers/ 
1/73 (H3N2) and influenza A/Puerto Rico/8/34 (H1N1). Both 
viruses were grown in fertilized hen's eggs. The mice were infected 
by the intranasal route with ~106-107 50% tissue culture infec- 
tive dose (TCIDs0) after pentobarbital  (0.1 mg i.p.) anesthesia. 
Virus was isolated from the mice by grinding the lungs and adding 
fresh triplicate 10-fold dilutions of 0.1-ml aliquots in MEM with 
10% FCS into Madin Darby canine kidney cells (3  x  104/well) 
in a 96-well plate. The plates were incubated at 34~  for 24 h, 
the media removed and replaced with MEM with 0.2% trypsin 
(Sigma Chemical Co., St. Louis, MO), incubated for an additional 
4 d at 34~  and 0.04 ml of 5% chicken red blood cell suspension 
added to each well. The plates were refrigerated for 2 h, and wells 
exhibiting  hemadsorption  were considered positive. The TCIDs0 
was calculated using the method of Reed and Muench (9). We found 
that TCIDs0 results are about 0.5 log10 lower than injecting virus 
into the allantoic cavity of fertilized hen's eggs (unpublished obser- 
cations). Log10 TCIDs0 of undetectable virus was defined as <-1. 
StatisticaIAnalysis.  All data were analyzed by Fisher's exact test. 
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dure of SPSS (SPSS, Inc., Chicago, IL) on a PDP 11/74 computer 
(Digital Electronics Corporation, Maynard, MA). 
Results and Discussion 
Clearance of Influenza  Virus.  After a total respiratory tract 
infection of normal young mice, virus reaches a peak titer 
of about 10  s TCIDs0, and is cleared from the lungs of most 
mice by days 6-8 (10, 11). This coincides with the peak pul- 
monary cellular immune response (10,  12, and our unpub- 
lished data).  To determine whether ~2-M (+/-) mice could 
eliminate influenza from their lungs similar to normal mice, 
we killed mice 8 d postchallenge with H3N2 virus. Similar 
to normal mice, the B2-M (+/-)  mice, which express class 
I MHC glycoproteins and have functional CD8 + CTLs, had 
all cleared virus by this day (Table 1). In contrast, 4/5 ~2-M 
(-/-)  mice (p < 0.05, Fisher's exact test) were still infected 
on this day (with a mean titer of 103"3). 
Table 1 also shows that by day 15, all three ~2-M (-/-) 
mice had cleared virus from their lungs. These data are con- 
sistent with Eichelberger et al. (7) who showed that on day 
10, only one of four B2-M (-/-)  mice was shedding virus 
(in undiluted lung homogenate), and on day 13, all mice had 
cleared virus. The mechanism for this clearance remains ob- 
scure. Although it is most likely mediated by CD4 + cells, 
Eichelberger et al. reported extremely low T  cell-mediated 
cytotoxicity in pulmonary lavage cells from influenza-infected 
~2-M (-/-)  mice (7). Similarly, CD4-  CD8-, 3//~ T cells 
are  believed to  be  nonphagocytic (7,  13),  and  the /32-M 
(-/-)  mice lack NK cell activity (7). Antiinfluenza IgG an- 
tibody alone is not believed to be sufficient for recovery from 
influenza infection (14), though a recent report suggests that 
a mixture of antiinfluenza IgA, IgG, and IgM antibodies may 
be (15). Because CD4 + and B lymphocytes are seemingly in- 
tact in the 82-M (-/-)  mice (7, 16), their antibody response 
should be normal. Hence, antibody differences do not seem 
to be able to explain the differences in viral clearance at day 
8, but could account for the eventual clearance. 
Table  1.  Clearance of H3N2  influenza  Virus after a 
Respiratory Tract Challenge 
Pulmonary Virus Titers  (Log10 TClDs0) 
Group  Day 8  Day 15 
/3z-M ( -  /  -)  <-  1,  1.45,  1.45,  4.2,  5.3  <-  1" 
/~2-M (+/-)  <-1"  ND 
Anesthetized/32-M  ( -  / -  ) and/32-M ( + / -  ) were infected intranasal- 
ly with rvl0~ TCIDs0 H3N2 virus, killed on days 8 and 15 post infec- 
tion, and virus quantitated by tissue culture.  Three of the firM ( -  / - ) 
mice died (on days 4, 6, and 10) vs two of the flz-M ( + / -  ) mice (on 
days 6 and 7). 
* All mice in these groups (five Bz-M [ + / - ] and three B2-M [ -  / -  ]) 
had titers <- 1. 
Survival after Challenge with a Nonvirulent  Influenza  Virus. 
When  anesthetized mice are inoculated intranasally with 
influenza, there is an initial infection of the total respiratory 
tract (nose, trachea, and lungs) (17). We therefore evaluated 
the effect of the ~2-M disruption on the ability of mice to 
survive by challenging the mice with a more virulent H1N1 
virus. Our results are shown in Fig. 1 and demonstrate that 
significantly more/82-M (-/-)  mice died than either B2-M 
(+/-) or control C57BL/6 mice. This difference is statisti- 
cally significant by either Fisher's exact test (B2-M [-/-]  vs. 
B2"M [+/-],  p  <  0.05;  Bz-M  [-/-]  vs.  C57BL/6,  p  < 
0.005),  or the survival analysis (Lee-Desu statistic  =  8.74, 
d.f.,  =  2, p  =  0.013;  ~2-M  [-/-]  vs.  ~2-M  [+/-],/J  : 
0.084;  /32-M [-/-]  vs.  C57BL/6, p  --  0.0054). 
Eichelberger et al. (7) evaluated viral clearance viral dear- 
ance from/32-M (-/-)  mice and found one of four and zero 
of four mice shedding virus at days 10 and 13, respectively. 
They also reported that mice depleted of CD8 + T  cells by 
anti-CD8 + antibody were similar to controls in that they 
shed virus on days 5 and 7, but not on days 10 or 13. Others, 
not reasonably, have interpreted this as normal recovery (15). 
Our data on viral shedding are consistent with Eichelberger 
et al. (7). However, having shown that on day 8 four of five 
/32-M (+/-)  mice and zero of five/3z-M (-/-)  mice shed 
virus, our data demonstrate a definite delay in viral clearance 
in the absence of CD8 § T cells. The pathologic significance 
of this defect is clearly illustrated by the challenge experi- 
ment using a more virulent strain of influenza virus (Fig. 
1). Functional CD8 + T cells are necessary for survival when 
the influenza virus challenge is more virulent. 
We agree with the conclusion of Eichelberger et al.  (7) 
that there is "a redundancy in cell-mediated effector mecha- 
nisms, at least  in young, healthy adult mice infected with 
a virus that grows mainly in surface epithelium:' However, 
our data show that CD8 + T  cells are essential  for recovery 
when the challenge is sufficiently virulent. Furthermore, deple- 
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Figure 1.  Survival of mice after respiratory challenge with influenza 
A H1N1. Homozygous/32-M (-/-) (n =  10), heterozygous ~2-M (+/-) 
(n  =  4), and C57BL/6 (BL/6)  (n =  10) mice were given '~107 TCIDso 
of H1N1 while under anesthesia and observed for 21 d. 
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and adoptive transfer of class II MHC-restricted clones en- 
hances influenza clearance, but has no significant effect on 
survival when a lethal dose of influenza is used (6). We con- 
clude that CD8 § class I MHC-restricted T  cells are the pri- 
mary mechanism responsible for recovery, as first proposed 
by Zinkernagel and Doherty (18). 
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